Healthequity es una sociedad de capital riesgo especializada en proyectos early-stage del sector salud: dispositivos médicos, biotecnología y servicios sanitarios.
Employees: 1-10
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 6
| Date | Name | Website | Total Raised | Location |
| 25.03.2022 | GlyCardial... | glycardial.com | $5M | Spain, Cat... |
| - | Minoryx Th... | minoryx.com | $106.01M | Spain, Cat... |
| - | PEPTOMYC | peptomyc.com | $20.05M | Spain, Cat... |
| - | Sanifit | sanifit.com | $123.17M | Spain, Bal... |
| - | nLife Ther... | n-life.es | $2.72M | - |
| - | Versantis | versantis.ch | $20.53M | Switzerlan... |
News 6
| Date | Title | Description |
| 20.09.2022 | Genfit To Acquire Versantis We’re pleased to announce our second exit in less than a year: Genfit has announced it will acquire Versantis. | - |
| 22.11.2021 | Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology | - |
| 29.03.2017 | Versantis raises CHF 4,4 million in series a financing to advance new generation of liver disease medicines | Versantis, a pharmaceutical company focused on the development of products addressing a high unmet medical need in the diagnosis, prevention, and treatment of liver diseases, today announces the closing of a Series A financing round of CH... |
| 28.04.2016 | Peptomyc completes Seed Funding of €1M | Peptomyc, a drug development company specialized in the discovery of new cancer treatments, today announces it has completed a Seed Funding Round of €1M. Healthequity SCR, a Spanish investment fund, led the round. The fundraising was also... |
| 31.03.2015 | Healthequity invests 750,000€ in biotech company Minoryx | Healthequity, the venture capital company promoted by the Medical Association of Barcelona (Col·legi de Metges de Barcelona, CoMB) and managed by Grup MED Corporatiu and Riva y García, formalizes its third operation. The fund has invested... |
| 20.06.2014 | Risk capital enters the biotech company from Granada, nLife | Healthequity, the venture capital company (SCR) of both the CoMB and financial services group Riva y García, has chosen the biotechnology firm nLife Therapeutics to make its first investment. The company is mainly owned by La Caixa - thr... |
Mentions in press and media 6
| Date | Title | Description |
| 16.12.2020 | Peptomyc cierra una ronda de €11,4M liderada por AurorA Science. Acuden también Alta Life Sciences, HealthEquity, el CDTI y business angels | 16/12/2020 Nota de prensa PEPTOMYC CIERRA UNA RONDA DE €11,4M LIDERADA POR AUROA SCIENCE. ACUDEN TAMBIÉN ALTA LIFE SCIENCES, HEALTHEQUITY, EL CDTI Y BUSINESS ANGELS. Peptomyc S.L., empresa biotecnológica especializada en el desarrollo de... |
| 18.09.2019 | Versantis obtain funds to fuel clinical trials | |
| 08.03.2019 | Albert Ferrer y Lluís Pareras, directivos de Healthequity, lanzan la gestora de capital riesgo Invivo Capital | 08/03/2019 ALBERT FERRER Y LLUÍS PARERAS, DIRECTIVOS DE HEALTHEQUITY, LANZAN LA GESTORA DE CAPITAL RIESGO INVIVO CAPITAL. Lluís Pareras y Albert Ferrer, directivos del fondo de capital riesgo (venture capital) Healthequity, han lanzado la... |
| 29.03.2017 | Versantis Raises CHF 4.4 Million in Series A Financing | |
| 14.10.2015 | Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M) | Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, today announces it has completed a Series A funding round of €19.4M ($21.7M). Ysios Capital, a Spanish investment fund, led the ... |
| 14.10.2015 | Minoryx Therapeutics cierra una ronda de €19,4M liderada por Ysios. Acuden CaixaCR, Kurma, Roche VF, Idinvest, Chiesi y Health Equity | 14/10/2015 MINORYX THERAPEUTICS CIERRA UNA RONDA DE €19,4 MILLONES LIDERADA POR YSIOS CAPITAL. ACUDEN CAIXA CAPITAL RISC, KURMA PARTNERS, ROCHE VENTURE FUND, IDINVEST, CHIESI VENTURES Y HEALTH EQUITY. Minoryx Therapeutics, una compañía es... |